AXT plans Beijing indium-phosphide wafer expansion while U.S. approvals remain unresolved

The order can be booked, the wafer can be made, and the customer can still be left waiting at the border. The delay sits between production and delivery.

The missing item is a Chinese export permit for indium-phosphide substrate—the wafer material used to make optical components. AXT’s Apr. 21 SEC filing and NTD’s report accessed Sept. 15 show the uncomfortable arrangement behind that wait. The California semiconductor-materials maker is raising money to expand indium-phosphide output at its Beijing subsidiary, while its ability to deliver abroad remains subject to approvals from the same country where that capacity sits.

A permit has therefore become part of the product, not a compliance detail after the sale.

NTD reported on Sept. 15 that AXT’s Chinese subsidiary began applying through an export-permit portal after it opened in March 2025. It received permits during 2025 for certain customers in Europe and Japan, but the company had not disclosed a timetable for approvals covering U.S. customers in its August filing.

That is the contradiction. Capacity expansion is being funded for a market in which shipment permission remains uncertain. A plant can add furnaces and staff; an exporter cannot load a controlled shipment until an authority has approved its application, NTD reported on Sept. 15.

NTD reported on Sept. 15 on the supply arrangement and this year’s backlog but did not establish which came first. AXT located the production expansion inside Beijing, and its Apr. 21 filing with the U.S. Securities and Exchange Commission says the new capital will financially support that subsidiary’s production effort. The filing says the capital is intended to support substrate expansion for worldwide export. The permit requirement creates the commercial consequence. Once a controlled product leaves that factory, the order still cannot move unless the required approval is granted.

Data-center construction may be bringing customers to AXT for more material. NTD reported on Sept. 15 that its account does not settle the size of either demand or licensing pressure. What it does establish is narrower and more useful: NTD reported that AXT identified permit approval, rather than factory output alone, as its principal obstacle to serving U.S. customers, while its applications remained unresolved in the August filing.

A plant can add furnaces and staff; an exporter cannot load a controlled shipment until an authority has approved its application.

The earlier European and Japanese permits are an important limit on the larger claim, NTD reported on Sept. 15. They show that a control list does not amount to a blanket export ban, and they leave room for applications to be approved later. They also show why a simple count of announced capacity misses the live risk. The practical measure is capacity that can actually reach a specific destination after the license decision, not the substrate capacity written into a capital-spending plan.

This is a familiar weakness in supply-chain accounting. A buyer can record inventory, a producer can report output, and a public company can report a backlog. None of those figures tells a customer whether a controlled shipment has permission to cross a border. The public clue is the change in disclosed approvals and the status of shipments bound for American customers, not a general measure of demand for artificial-intelligence infrastructure.

The funded expansion at Beijing Tongmei Xtal Technology is a planned capacity response, not evidence that additional capacity is complete, qualified, or cleared for any particular destination, according to AXT’s Apr. 21 filing with the U.S. Securities and Exchange Commission. That distinction matters. A larger factory changes the amount that could be shipped. It does not change the approval status of an order already held at the export gate.

For a buyer that needs wafers for a production run, the pressure is measured in the interval between an approved order and a shipment. For a manufacturer expanding a substrate plant, the response is measured in construction, testing and customer approval. Those clocks do not run at the same speed.

The market exposure is therefore concentrated in optical-component supply chains tied to indium phosphide and in contracts dependent on Chinese-made substrate, as NTD reported on Sept. 15. The evidence does not show that all shipments have stopped, nor does it identify the inventory held by every downstream customer. It shows a narrower choke point. An unresolved permit can keep contracted material from becoming usable supply.

NTD reported on Sept. 15 that AXT’s August filing left the timetable for U.S. permits unresolved. AXT’s next filing will show whether it discloses permits covering U.S. customers and resumed shipments. If those permits are granted and shipments resume without AXT continuing to report that deliveries are constrained, the permit-centered explanation weakens and demand becomes the stronger explanation.

NTD reported on Sept. 15 that AXT’s August filing described unresolved approvals for American shipments and backlogged orders. If AXT’s filings continue to show those conditions, the permit remains the measure that matters.

A permit looks like paperwork only until a factory is waiting for the material it was meant to release to a U.S. customer.